{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T14:39:13Z","timestamp":1793716753623,"version":"4.6.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T00:00:00Z","timestamp":1753228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T00:00:00Z","timestamp":1753228800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005788","name":"Medical University of Vienna","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005788","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>\n                      Lymphovascular invasion (LVI) in non-small cell lung cancer (NSCLC) is a critical prognostic marker linked to higher risks of metastasis and recurrence. This study aimed to develop a non-invasive predictive model using body composition features from\n                      <jats:sup>18<\/jats:sup>\n                      F-FDG PET\/CT imaging to assess LVI risk in early-stage NSCLC patients.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We retrospectively analyzed 248 patients, including 153 from Vienna (training cohort) and 95 from Budapest (validation cohort). Preoperative\n                      <jats:sup>18<\/jats:sup>\n                      F-FDG PET\/CT scans were used to assess tumor metabolic parameters, including standardized uptake values (SUVmax, SUVmean), metabolic tumor volume (MTV), and total lesion glycolysis (TLG), as well as body composition features, including visceral, subcutaneous, and intermuscular adipose tissue, skeletal muscle at L1\u2013L5. LASSO regression identified key body composition features, and a logistic regression-based nomogram was constructed and validated through ROC analysis, calibration, decision curve analysis, and survival analysis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      LVI was present in 66\/153 (43.1%) of Vienna and 39\/95 (41.1%) of Budapest patients. The nomogram, developed using the Vienna training cohort, incorporating MTV, N stage, and body composition achieved an AUC of 0.839 and 0.790 in the Budapest validation cohort. Statistical tests confirmed that the nomogram significantly outperformed models based on either clinical (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20097.92e-06) or imaging variables alone (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.0474). Furthermore, LVI predicted by the nomogram was associated with significantly poorer 3-year recurrence-free and 5-year survival.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Integrating body composition with clinical and tumor metabolic features from PET\/CT enables preoperative prediction of LVI in NSCLC, supporting improved risk stratification.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1007\/s00259-025-07435-4","type":"journal-article","created":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T08:26:32Z","timestamp":1753259192000},"page":"774-785","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Using 18F-FDG PET\/CT-derived body composition features to predict lymphovascular invasion in non-small cell lung cancer"],"prefix":"10.1007","volume":"53","author":[{"given":"Zewen","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Haberl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clemens","family":"Spielvogel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Szabolcs","family":"Szakall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Molnar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Lungu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janos","family":"Fillinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferenc","family":"Renyi-Vamos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clemens","family":"Aigner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balazs","family":"Dome","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas","family":"Kenner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zsolt","family":"Megyesfalvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4222-4083","authenticated-orcid":false,"given":"Marcus","family":"Hacker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,23]]},"reference":[{"key":"7435_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363. https:\/\/doi.org\/10.3322\/caac.21834.","journal-title":"CA Cancer J Clin"},{"key":"7435_CR2","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.jtho.2021.11.003","volume":"17","author":"AG Nicholson","year":"2022","unstructured":"Nicholson AG, Tsao MS, Beasley MB, et al. The 2021 WHO classification of lung tumors: impact of advances since 2015. J Thorac Oncol. 2022;17:362\u201387. https:\/\/doi.org\/10.1016\/j.jtho.2021.11.003.","journal-title":"J Thorac Oncol"},{"key":"7435_CR3","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1016\/j.jtho.2016.06.028","volume":"11","author":"FC Detterbeck","year":"2016","unstructured":"Detterbeck FC, Chansky K, Groome P, et al. The IASLC lung cancer staging project: methodology and validation used in the development of proposals for revision of the stage classification of NSCLC in the forthcoming (Eighth) Edition of the TNM classification of lung cancer. J Thorac Oncol. 2016;11:1433\u201346. https:\/\/doi.org\/10.1016\/j.jtho.2016.06.028.","journal-title":"J Thorac Oncol"},{"key":"7435_CR4","doi-asserted-by":"publisher","first-page":"242","DOI":"10.3978\/j.issn.2218-6751.2013.12.05","volume":"3","author":"H Uramoto","year":"2014","unstructured":"Uramoto H, Tanaka F. Recurrence after surgery in patients with NSCLC. Transl Lung Cancer Res. 2014;3:242\u20139. https:\/\/doi.org\/10.3978\/j.issn.2218-6751.2013.12.05.","journal-title":"Transl Lung Cancer Res"},{"key":"7435_CR5","doi-asserted-by":"publisher","unstructured":"Kuhn E, Gambini D, Despini L, Asnaghi D, Runza L, Ferrero S. Updates on Lymphovascular Invasion in Breast Cancer. Biomedicines 2023;11. https:\/\/doi.org\/10.3390\/biomedicines11030968.","DOI":"10.3390\/biomedicines11030968"},{"key":"7435_CR6","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.urolonc.2022.01.014","volume":"40","author":"J Stangl-Kremser","year":"2022","unstructured":"Stangl-Kremser J, Muto G, Grosso AA, et al. The impact of lymphovascular invasion in patients treated with radical nephroureterectomy for upper tract urothelial carcinoma: An extensive updated systematic review and meta-analysis. Urol Oncol. 2022;40:243\u201361. https:\/\/doi.org\/10.1016\/j.urolonc.2022.01.014.","journal-title":"Urol Oncol"},{"key":"7435_CR7","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1159\/000488859","volume":"95","author":"SY Sung","year":"2018","unstructured":"Sung SY, Kwak Y-K, Lee S-W, et al. Lymphovascular invasion increases the risk of nodal and distant recurrence in node-negative stage I-IIA non-small-cell lung cancer. Oncology. 2018;95:156\u201362. https:\/\/doi.org\/10.1159\/000488859.","journal-title":"Oncology"},{"key":"7435_CR8","doi-asserted-by":"publisher","first-page":"1269971","DOI":"10.3389\/fonc.2023.1269971","volume":"13","author":"SJ Lee","year":"2023","unstructured":"Lee SJ, Go J, Ahn BS, et al. Lymphovascular invasion is an independent prognostic factor in breast cancer irrespective of axillary node metastasis and molecular subtypes. Front Oncol. 2023;13:1269971. https:\/\/doi.org\/10.3389\/fonc.2023.1269971.","journal-title":"Front Oncol"},{"key":"7435_CR9","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/j.athoracsur.2013.11.002","volume":"97","author":"NM Mollberg","year":"2014","unstructured":"Mollberg NM, Bennette C, Howell E, Backhus L, Devine B, Ferguson MK. Lymphovascular invasion as a prognostic indicator in stage I non-small cell lung cancer: a systematic review and meta-analysis. Ann Thorac Surg. 2014;97:965\u201371. https:\/\/doi.org\/10.1016\/j.athoracsur.2013.11.002.","journal-title":"Ann Thorac Surg"},{"key":"7435_CR10","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s10549-017-4610-0","volume":"169","author":"A-S Hamy","year":"2018","unstructured":"Hamy A-S, Lam G-T, Laas E, et al. Lymphovascular invasion after neoadjuvant chemotherapy is strongly associated with poor prognosis in breast carcinoma. Breast Cancer Res Treat. 2018;169:295\u2013304. https:\/\/doi.org\/10.1007\/s10549-017-4610-0.","journal-title":"Breast Cancer Res Treat"},{"key":"7435_CR11","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.lungcan.2019.04.024","volume":"133","author":"X Li","year":"2019","unstructured":"Li X, Zhang C, Sun Z, et al. Propensity-matched analysis of adjuvant chemotherapy for completely resected Stage IB non-small-cell lung cancer patients. Lung Cancer. 2019;133:75\u201382. https:\/\/doi.org\/10.1016\/j.lungcan.2019.04.024.","journal-title":"Lung Cancer"},{"key":"7435_CR12","doi-asserted-by":"publisher","first-page":"1185808","DOI":"10.3389\/fonc.2023.1185808","volume":"13","author":"J Wang","year":"2023","unstructured":"Wang J, Zheng Z, Zhang Y, et al. 18F-FDG PET\/CT radiomics for prediction of lymphovascular invasion in patients with early-stage non-small cell lung cancer. Front Oncol. 2023;13:1185808. https:\/\/doi.org\/10.3389\/fonc.2023.1185808.","journal-title":"Front Oncol"},{"key":"7435_CR13","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.2214\/AJR.21.25814","volume":"217","author":"C Li","year":"2021","unstructured":"Li C, Tian Y, Shen Y, Wen B, He Y. Utility of volumetric metabolic parameters on preoperative FDG PET\/CT for predicting tumor lymphovascular invasion in non-small cell lung cancer. Am J Roentgenol. 2021;217:1433\u201343. https:\/\/doi.org\/10.2214\/AJR.21.25814.","journal-title":"Am J Roentgenol"},{"key":"7435_CR14","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s12149-015-1023-1","volume":"30","author":"Y Noda","year":"2016","unstructured":"Noda Y, Goshima S, Kanematsu M, et al. F-18 FDG uptake on positron emission tomography as a predictor for lymphovascular invasion in patients with lung adenocarcinoma. Ann Nucl Med. 2016;30:11\u20137. https:\/\/doi.org\/10.1007\/s12149-015-1023-1.","journal-title":"Ann Nucl Med"},{"key":"7435_CR15","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1097\/JTO.0b013e3181f9abca","volume":"6","author":"S Shiono","year":"2011","unstructured":"Shiono S, Abiko M, Sato T. Positron emission tomography\/computed tomography and lymphovascular invasion predict recurrence in stage I lung cancers. J Thorac Oncol. 2011;6:43\u20137. https:\/\/doi.org\/10.1097\/JTO.0b013e3181f9abca.","journal-title":"J Thorac Oncol"},{"key":"7435_CR16","doi-asserted-by":"publisher","unstructured":"Hosseini SA, Hajianfar G, Ghaffarian P, et al. PET radiomics-based lymphovascular invasion prediction in lung cancer using multiple segmentation and multi-machine learning algorithms. Australas Phys EngSci Med 2024; published online Sept 3. https:\/\/doi.org\/10.1007\/s13246-024-01475-0.","DOI":"10.1007\/s13246-024-01475-0"},{"key":"7435_CR17","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1093\/jncimonographs\/lgad001","volume":"2023","author":"UA Shah","year":"2023","unstructured":"Shah UA, Ballinger TJ, Bhandari R, et al. Imaging modalities for measuring body composition in patients with cancer: opportunities and challenges. J Natl Cancer Inst Monogr. 2023;2023:56\u201367. https:\/\/doi.org\/10.1093\/jncimonographs\/lgad001.","journal-title":"J Natl Cancer Inst Monogr"},{"key":"7435_CR18","doi-asserted-by":"publisher","first-page":"1133S","DOI":"10.3945\/ajcn.2010.28608C","volume":"91","author":"VE Baracos","year":"2010","unstructured":"Baracos VE, Reiman T, Mourtzakis M, Gioulbasanis I, Antoun S. Body composition in patients with non-small cell lung cancer: a contemporary view of cancer cachexia with the use of computed tomography image analysis. Am J Clin Nutr. 2010;91:1133S-1137S. https:\/\/doi.org\/10.3945\/ajcn.2010.28608C.","journal-title":"Am J Clin Nutr"},{"key":"7435_CR19","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1002\/jcsm.13205","volume":"14","author":"H-L Xie","year":"2023","unstructured":"Xie H-L, Ruan G-T, Wei L, et al. The prognostic value of the combination of body composition and systemic inflammation in patients with cancer cachexia. J Cachexia Sarcopenia Muscle. 2023;14:879\u201390. https:\/\/doi.org\/10.1002\/jcsm.13205.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"7435_CR20","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1038\/s41591-023-02232-8","volume":"29","author":"O Al-Sawaf","year":"2023","unstructured":"Al-Sawaf O, Weiss J, Skrzypski M, et al. Body composition and lung cancer-associated cachexia in TRACERx. Nat Med. 2023;29:846\u201358. https:\/\/doi.org\/10.1038\/s41591-023-02232-8.","journal-title":"Nat Med"},{"key":"7435_CR21","doi-asserted-by":"publisher","first-page":"17106","DOI":"10.1038\/nrdp.2017.105","volume":"4","author":"VE Baracos","year":"2018","unstructured":"Baracos VE, Martin L, Korc M, Guttridge DC, Fearon KCH. Cancer-associated cachexia. Nat Rev Dis Primers. 2018;4:17106. https:\/\/doi.org\/10.1038\/nrdp.2017.105.","journal-title":"Nat Rev Dis Primers"},{"key":"7435_CR22","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","volume":"12","author":"K Fearon","year":"2011","unstructured":"Fearon K, Strasser F, Anker SD, et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol. 2011;12:489\u201395. https:\/\/doi.org\/10.1016\/S1470-2045(10)70218-7.","journal-title":"Lancet Oncol"},{"key":"7435_CR23","doi-asserted-by":"publisher","unstructured":"Wang G, Otto CC, Heij LR, et al. Impact of altered body composition on clinical and oncological outcomes in intrahepatic cholangiocarcinoma. J Clin Med Res 2023;12. https:\/\/doi.org\/10.3390\/jcm12247747.","DOI":"10.3390\/jcm12247747"},{"key":"7435_CR24","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s40364-023-00527-z","volume":"11","author":"X-C Mao","year":"2023","unstructured":"Mao X-C, Shi S, Yan L-J, et al. A model based on adipose and muscle-related indicators evaluated by CT images for predicting microvascular invasion in HCC patients. Biomark Res. 2023;11:87. https:\/\/doi.org\/10.1186\/s40364-023-00527-z.","journal-title":"Biomark Res"},{"key":"7435_CR25","doi-asserted-by":"publisher","first-page":"1176425","DOI":"10.3389\/fonc.2023.1176425","volume":"13","author":"M Rozynek","year":"2023","unstructured":"Rozynek M, Gut D, Kucyba\u0142a I, et al. Fully automated 3D body composition analysis and its association with overall survival in head and neck squamous cell carcinoma patients. Front Oncol. 2023;13:1176425. https:\/\/doi.org\/10.3389\/fonc.2023.1176425.","journal-title":"Front Oncol"},{"key":"7435_CR26","doi-asserted-by":"publisher","unstructured":"Wang J, Yang Y, Xie Z, et al. Predicting lymphovascular invasion in non-small cell lung cancer using deep convolutional neural networks on preoperative chest CT. AcadRadiol 2024; published online June 5. 2024.05.010. https:\/\/doi.org\/10.1016\/j.acra.2024.05.010.","DOI":"10.1016\/j.acra.2024.05.010"},{"key":"7435_CR27","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1007\/s00330-022-09109-3","volume":"33","author":"Q Chen","year":"2023","unstructured":"Chen Q, Shao J, Xue T, et al. Intratumoral and peritumoral radiomics nomograms for the preoperative prediction of lymphovascular invasion and overall survival in non-small cell lung cancer. Eur Radiol. 2023;33:947\u201358. https:\/\/doi.org\/10.1007\/s00330-022-09109-3.","journal-title":"Eur Radiol"},{"key":"7435_CR28","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1007\/s00259-019-04585-0","volume":"47","author":"S Shrestha","year":"2020","unstructured":"Shrestha S, Higuchi T, Shirai K, et al. Prognostic significance of semi-quantitative FDG-PET parameters in stage I non-small cell lung cancer treated with carbon-ion radiotherapy. Eur J Nucl Med Mol Imaging. 2020;47:1220\u20137. https:\/\/doi.org\/10.1007\/s00259-019-04585-0.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7435_CR29","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1097\/JTO.0b013e3182519a42","volume":"7","author":"KA Higgins","year":"2012","unstructured":"Higgins KA, Chino JP, Ready N, et al. Lymphovascular invasion in non-small-cell lung cancer: implications for staging and adjuvant therapy. J Thorac Oncol. 2012;7:1141\u20137. https:\/\/doi.org\/10.1097\/JTO.0b013e3182519a42.","journal-title":"J Thorac Oncol"},{"key":"7435_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2023.107189","volume":"179","author":"NS Gezer","year":"2023","unstructured":"Gezer NS, Bandos AI, Beeche CA, Leader JK, Dhupar R, Pu J. CT-derived body composition associated with lung cancer recurrence after surgery. Lung Cancer. 2023;179: 107189. https:\/\/doi.org\/10.1016\/j.lungcan.2023.107189.","journal-title":"Lung Cancer"},{"key":"7435_CR31","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.lungcan.2013.11.025","volume":"83","author":"K Kaira","year":"2014","unstructured":"Kaira K, Serizawa M, Koh Y, et al. Biological significance of 18F-FDG uptake on PET in patients with non-small-cell lung cancer. Lung Cancer. 2014;83:197\u2013204. https:\/\/doi.org\/10.1016\/j.lungcan.2013.11.025.","journal-title":"Lung Cancer"},{"key":"7435_CR32","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.lungcan.2020.04.033","volume":"146","author":"JK Yun","year":"2020","unstructured":"Yun JK, Lee GD, Choi S, et al. Comparison of prognostic impact of lymphovascular invasion in stage IA non-small cell lung cancer after lobectomy versus sublobar resection: A propensity score-matched analysis. Lung Cancer. 2020;146:105\u201311. https:\/\/doi.org\/10.1016\/j.lungcan.2020.04.033.","journal-title":"Lung Cancer"},{"key":"7435_CR33","doi-asserted-by":"publisher","first-page":"8500","DOI":"10.1016\/j.athoracsur.2021.04.108","volume":"37","author":"Y Tsutani","year":"2019","unstructured":"Tsutani Y, Imai K, Ito H, et al. Adjuvant chemotherapy for pathological stage I non-small cell lung cancer with high-risk factors for recurrence: A multicenter study. J Clin Oncol. 2019;37:8500\u20138500. https:\/\/doi.org\/10.1016\/j.athoracsur.2021.04.108.","journal-title":"J Clin Oncol"},{"key":"7435_CR34","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1172\/JCI29881","volume":"117","author":"CN Lumeng","year":"2007","unstructured":"Lumeng CN, Bodzin JL, Saltiel AR. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest. 2007;117:175\u201384. https:\/\/doi.org\/10.1172\/JCI29881.","journal-title":"J Clin Invest"},{"key":"7435_CR35","doi-asserted-by":"publisher","first-page":"5177","DOI":"10.3748\/wjg.v20.i18.5177","volume":"20","author":"S Riondino","year":"2014","unstructured":"Riondino S, Roselli M, Palmirotta R, Della-Morte D, Ferroni P, Guadagni F. Obesity and colorectal cancer: role of adipokines in tumor initiation and progression. World J Gastroenterol. 2014;20:5177\u201390. https:\/\/doi.org\/10.3748\/wjg.v20.i18.5177.","journal-title":"World J Gastroenterol"},{"key":"7435_CR36","doi-asserted-by":"publisher","first-page":"4075","DOI":"10.1016\/j.clnu.2021.02.010","volume":"40","author":"AD da Cunha J\u00fanior","year":"2021","unstructured":"da Cunha J\u00fanior AD, Silveira MN, Takahashi MES, et al. Visceral adipose tissue glucose uptake is linked to prognosis in multiple myeloma patients: An exploratory study. Clin Nutr. 2021;40:4075\u201384. https:\/\/doi.org\/10.1016\/j.clnu.2021.02.010.","journal-title":"Clin Nutr"},{"key":"7435_CR37","doi-asserted-by":"publisher","first-page":"e0148776","DOI":"10.1371\/journal.pone.0148776","volume":"11","author":"K Pahk","year":"2016","unstructured":"Pahk K, Rhee S, Kim S, Choe JG. Predictive role of functional visceral fat activity assessed by preoperative F-18 FDG PET\/CT for regional lymph node or distant metastasis in patients with colorectal cancer. PLoS ONE. 2016;11:e0148776. https:\/\/doi.org\/10.1371\/journal.pone.0148776.","journal-title":"PLoS ONE"},{"key":"7435_CR38","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1038\/bmt.2014.71","volume":"49","author":"KR Carson","year":"2014","unstructured":"Carson KR, Bates ML, Tomasson MH. The skinny on obesity and plasma cell myeloma: a review of the literature. Bone Marrow Transplant. 2014;49:1009\u201315. https:\/\/doi.org\/10.1038\/bmt.2014.71.","journal-title":"Bone Marrow Transplant"},{"key":"7435_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/obr.12335","volume":"17","author":"V Dam","year":"2016","unstructured":"Dam V, Sikder T, Santosa S. From neutrophils to macrophages: differences in regional adipose tissue depots. Obes Rev. 2016;17:1\u201317. https:\/\/doi.org\/10.1111\/obr.12335.","journal-title":"Obes Rev"},{"key":"7435_CR40","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.3390\/genes11091092","volume":"11","author":"M Ma\u0142odobra-Mazur","year":"2020","unstructured":"Ma\u0142odobra-Mazur M, Cierzniak A, Pawe\u0142ka D, Kaliszewski K, Rudnicki J, Dobosz T. Metabolic differences between subcutaneous and visceral adipocytes differentiated with an excess of saturated and monounsaturated fatty acids. Genes. 2020;11:1092.","journal-title":"Genes"},{"key":"7435_CR41","doi-asserted-by":"publisher","first-page":"435","DOI":"10.3390\/genes11091092","volume":"179","author":"T Iwase","year":"2020","unstructured":"Iwase T, Sangai T, Fujimoto H, et al. Quality and quantity of visceral fat tissue are associated with insulin resistance and survival outcomes after chemotherapy in patients with breast cancer. Breast Cancer Res Treat. 2020;179:435\u201343. https:\/\/doi.org\/10.3390\/genes11091092.","journal-title":"Breast Cancer Res Treat"},{"key":"7435_CR42","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1016\/j.clnu.2024.05.040","volume":"43","author":"Y Sun","year":"2024","unstructured":"Sun Y, Deng M, Gevaert O, et al. Tumor metabolic activity is associated with subcutaneous adipose tissue radiodensity and survival in non-small cell lung cancer. Clin Nutr. 2024;43:1809\u201315. https:\/\/doi.org\/10.1016\/j.clnu.2024.05.040.","journal-title":"Clin Nutr"},{"key":"7435_CR43","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1007\/s00520-017-3902-6","volume":"26","author":"E Deluche","year":"2018","unstructured":"Deluche E, Leobon S, Desport JC, Venat-Bouvet L, Usseglio J, Tubiana-Mathieu N. Impact of body composition on outcome in patients with early breast cancer. Support Care Cancer. 2018;26:861\u20138. https:\/\/doi.org\/10.1007\/s00520-017-3902-6.","journal-title":"Support Care Cancer"},{"key":"7435_CR44","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/s41574-022-00784-2","volume":"19","author":"BH Goodpaster","year":"2023","unstructured":"Goodpaster BH, Bergman BC, Brennan AM, Sparks LM. Intermuscular adipose tissue in metabolic disease. Nat Rev Endocrinol. 2023;19:285\u201398. https:\/\/doi.org\/10.1038\/s41574-022-00784-2.","journal-title":"Nat Rev Endocrinol"},{"key":"7435_CR45","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.21037\/tcr-22-123","volume":"11","author":"C Zheng","year":"2022","unstructured":"Zheng C, Chen X, Zhang Z, et al. Nomogram based on intramuscular adipose tissue content for predicting the prognosis of patients with gallbladder cancer after radical resection. Transl Cancer Res. 2022;11:1898\u2013908. https:\/\/doi.org\/10.21037\/tcr-22-123.","journal-title":"Transl Cancer Res"},{"key":"7435_CR46","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1002\/jcsm.13371","volume":"14","author":"R Liu","year":"2023","unstructured":"Liu R, Qiu Z, Zhang L, et al. High intramuscular adipose tissue content associated with prognosis and postoperative complications of cancers. J Cachexia Sarcopenia Muscle. 2023;14:2509\u201319. https:\/\/doi.org\/10.1002\/jcsm.13371.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"7435_CR47","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/s41698-021-00248-2","volume":"6","author":"BP Leitner","year":"2022","unstructured":"Leitner BP, Givechian KB, Ospanova S, Beisenbayeva A, Politi K, Perry RJ. Multimodal analysis suggests differential immuno-metabolic crosstalk in lung squamous cell carcinoma and adenocarcinoma. NPJ Precis Oncol. 2022;6:8. https:\/\/doi.org\/10.1038\/s41698-021-00248-2.","journal-title":"NPJ Precis Oncol"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-025-07435-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-025-07435-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-025-07435-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T02:46:28Z","timestamp":1769222788000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-025-07435-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,23]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["7435"],"URL":"https:\/\/doi.org\/10.1007\/s00259-025-07435-4","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,23]]},"assertion":[{"value":"5 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective study was approved by the Institutional Review Board of the Medical University of Vienna (ID 1649\/2016) and the Research Committee of the Hungarian Medical Research Council (52614\u20134\/2013\/EKU). A waiver of informed consent was granted due to the retrospective nature of the analysis.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors declare no conflicts of interest relevant to this study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}